Pem and the Cost of Multicycle Maintenance
Biomarkers Are Here to Stay for Clinical Research and Standard Care
Review of Ongoing Clinical Trials in Non-small Cell Lung Cancer
Apelin Expression in Human Non-small Cell Lung Cancer
Spectrum of LKB1, EGFR, and KRAS Mutations in Chinese Lung Adenocarcinomas
Correlation Between HLA Alleles and EGFR Mutation in Japanese Patients with Adenocarcinoma of the Lung
Genetic Determinants of Pemetrexed Responsiveness and Nonresponsiveness in Non-small Cell Lung Cancer Cells
Polymorphisms in the Caspase Genes and the Risk of Lung Cancer
Metastasis-Associated Protein 1 Nuclear Expression is Associated with Tumor Progression and Clinical Outcome in Patients with Non-small Cell Lung Cancer
Co-Overexpression of Cyclooxygenase-2 and Microsomal Prostaglandin E Synthase-1 Adversely Affects the Postoperative Survival in Non-small Cell Lung Cancer
Prognostic Implications of Epidermal Growth Factor Receptor and KRAS Gene Mutations and Epidermal Growth Factor Receptor Gene Copy Numbers in Patients with Surgically Resectable Non-small Cell Lung Cancer in Taiwan
Korean Ethnicity as Compared with White Ethnicity Is an Independent Favorable Prognostic Factor for Overall Survival in Non-small Cell Lung Cancer before and after the Oral Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Era
Frequency of EGFR and KRAS Mutations in Japanese Patients with Lung Adenocarcinoma with Features of the Mucinous Subtype of Bronchioloalveolar Carcinoma
The Clinical Value of Lymphatic Micrometastases in Patients with Non-small Cell Lung Cancer
A Pragmatic Approach to the Diagnosis of Nodal Micrometastases in Early Stage Non-small Cell Lung Cancer
Clinical Features of Bronchioloalveolar Carcinoma with New Histologic and Staging Definitions
Current Dyspnea Among Long-Term Survivors of Early-Stage Non-small Cell Lung Cancer
What Should a Support Program for People with Lung Cancer Look Like? Differing Attitudes of Patients and Support Group Facilitators
Screening for Lung Cancer with Low-Dose Computed Tomography
The Finding of Premalignant Lesions is Not Associated with Smoking Cessation in Chemoprevention Study Volunteers
Long-Term Outcome and Late Recurrence in Patients with Completely Resected Stage IA Non-small Cell Lung Cancer
Prognostic Factors for Pulmonary Metastasectomy in the Treatment of Hepatocellular Carcinoma
Concurrent Chemotherapy and Short Course Radiotherapy in Patients with Stage IIIA to IIIB Non-small Cell Lung Cancer Not Eligible for Radical Treatment
Cost-Effectiveness of Pemetrexed as First-Line Maintenance Therapy for Advanced Nonsquamous Non-small Cell Lung Cancer
MicroRNA 92a-2*
Phase II Study of Cediranib (AZD 2171), an Inhibitor of the Vascular Endothelial Growth Factor Receptor, for Second-Line Therapy of Small Cell Lung Cancer (National Cancer Institute #7097)
A Phase I Study of Vandetanib in Combination with Vinorelbine/Cisplatin or Gemcitabine/Cisplatin as First-Line Treatment for Advanced Non-small Cell Lung Cancer
Bilateral Choroidal Metastasis as the Presenting Sign of Small Cell Lung Carcinoma
Bronchoscopy in Lung Cancer
Metastatic Angiosarcoma Arising From the Right Atrium
Chylopericardium Caused by Non-small Cell Lung Cancer
Best of the Month
Gemcitabine-Induced Acute Eosinophilic Pneumonia
Prospective Study of Lambert-Eaton Myasthenic Syndrome in Small Cell Lung Cancer
Differences of Gene Expression in Non-small Cell Lung Cancer
Differences of Gene Expression in Non-small Cell Lung Cancer
Serum Concentrations of Erlotinib at a Dose of 25 mg Daily